These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4762281)

  • 21. Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
    Kwaan HC
    Thromb Diath Haemorrh Suppl; 1973; 56():239-51. PubMed ID: 4617331
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 24. Vein surgery during defibrinogenation.
    Browse NL; Clemenson G
    Br J Surg; 1978 Jul; 65(7):452-5. PubMed ID: 149578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 26. Significane of intravascular coagulation in canine endotoxin shock.
    From AH; Spink WW; Knight D; Gewurz H
    Infect Immun; 1975 May; 11(5):1010-3. PubMed ID: 1091556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular coagulation in the lungs in experimental fat embolism.
    Saldeen T
    Acta Chir Scand; 1969; 135(8):653-62. PubMed ID: 5368950
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood and neoplastic diseases. Thrombosis: treatment and prophylaxis.
    Browse NL
    Br Med J; 1974 Oct; 4(5936):96-9. PubMed ID: 4412220
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombolytic agents and lysis of coronary artery thrombosis.
    Moschos CB; Burke WM; Lehan PH; Oldewurtel HA; Regan TJ
    Cardiovasc Res; 1970 Apr; 4(2):228-34. PubMed ID: 5419811
    [No Abstract]   [Full Text] [Related]  

  • 30. Further experience in the use of ancrod (Arvin) to prevent thrombosis on prosthetic heart valves.
    Singh MP; Pitney WR; Melrose DG
    Thorax; 1971 Mar; 26(2):167-71. PubMed ID: 5576533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ancrod and heparin as anticoagulants following endarterectomy in the dog.
    Daniel TM; Pizzo SV; Mckee PA
    Ann Surg; 1976 Aug; 184(2):223-8. PubMed ID: 952568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses.
    Olsson E; Asko-Seljavaara S; Lassila R
    Thromb Haemost; 2002 Feb; 87(2):245-51. PubMed ID: 11858484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Disseminated intravascular coagulation in the newborn. Presentation of 5 cases].
    Soliani M; Moretti R; Pallecchi AE; Silvestri G; Flossa S; Marino C; Farina MP; Nitti P
    Minerva Pediatr; 1973 Jun; 25(23):975-91. PubMed ID: 4745025
    [No Abstract]   [Full Text] [Related]  

  • 34. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
    Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM
    J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
    Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG
    J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effect of reptilase on fibrinogen metabolism in dogs.
    Egberg N; Nordström S
    Scand J Clin Lab Invest; 1969 Dec; 24(4):383-5. PubMed ID: 5309883
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of Reptilase R and thrombin clotting time in the presence of fibrinogen degradation products and heparin.
    Latallo ZS; Teisseyre E
    Scand J Haematol Suppl; 1971; 13():261-6. PubMed ID: 5290690
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical experience with brinase.
    Frisch EP
    J Clin Pathol; 1972 Jul; 25(7):654-5. PubMed ID: 5070274
    [No Abstract]   [Full Text] [Related]  

  • 39. Coagulation studies in patients treated with defibrase.
    Egberg N
    Acta Med Scand; 1973 Oct; 194(4):291-302. PubMed ID: 4749167
    [No Abstract]   [Full Text] [Related]  

  • 40. Reptilase-induced shortening of coagulation times in normal and hemophilic individuals.
    Harder AJ; Stadelmann H; Straub PW
    Thromb Diath Haemorrh; 1972 Apr; 27(2):349-60. PubMed ID: 5065649
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.